NUVALENT, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 67.8 USD | +2.60% |
|
-1.63% | -8.25% |
| 09/05 | Nuvalent Q1 Net Loss Widens | MT |
| 09/05 | Nuvalent, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 426.59Cr | - | - | - | - | - | |
| 4.82TCr | - | |||||
| 4.17TCr | ||||||
| 4.1TCr | ||||||
| 2.88TCr | ||||||
| 2.56TCr |
- Stock Market
- Equities
- NUVL Stock
- Charts Nuvalent, Inc.
- Sector Chart